Back to search
Patent Foramen Ovale (PFO)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Patent Foramen Ovale (PFO) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Patent Foramen Ovale (PFO) trials you may qualify forThis study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator educatio…
The Abbott Structural Heart (SH) Registry is being conducted to confirm the safety and performance of Abbott's SH devices in a post-market, real-world setting.…
Every fetus has a small hole in their heart, called a foramen ovale when they are developing in the womb. For most people this hole closes shortly after birth,…
To assess whether PFO closure plus antiplatelet therapy is superior to antiplatelet therapy alone and whether oral anticoagulant therapy is superior to antiplat…
To determine the safety of antithrombotic treatment discontinuation 12 months following successful transcatheter PFO closure.
Patent foramen ovale (PFO) is an important mechanism of embolic stroke of undetermined source (ESUS). Current guidelines recommend PFO closure for high-risk PFO…
This study is a prospective, multicenter, randomized, controlled, single-blind, investigator-driven, non-profit clinical trial designed to compare the safety an…
A single-arm, non-randomized, multi-center clinical study of the Amplatzer™ Trevisio™ Intravascular Delivery System for facilitating percutaneous, transcatheter…